Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01807689 · ClinicalTrials.gov registry record
Salivary Biomarkers for Sjögren's Syndrome Detection
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 420
- Enrollment target
NCT01807689 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 420 participants.
The verdict
NCT01807689 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 420 participants
- Enrollment target
Study Summary
This is a multi-center clinical study to compare the performance of a collective panel of salivary biomarkers to discriminate SS from non-SS in sicca cohorts recruited from three clinical sites with the diagnostic outcomes based on the new classification criteria for Sjögren's syndrome by the American College of Rheumatology (ACR) developed in 2012. This is not a treatment study, but a pilot study to confirm diagnostic ability of a panel of salivary biomarkers. All enrolled subjects must be classified as having both oral and ocular sicca symptoms without another autoimmune/connective tissue disease (Appendix 2). At the University of California in Los Angeles, using molecular techniques, we will quantify discriminatory biomarkers in saliva collected from enrolled subjects, who are also being evaluated as part of their clinical care using the standard diagnostic tests of the 2002 AECG criteria. We also will test the performance of these biomarkers to predict the diagnosis of pSS according to the AECG criteria, as these are the most widely used tests to diagnose pSS and assess disease activity worldwide.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2013-04-01 |
| Est. Completion | 2018-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01807689
The ClinicalTrials.gov registry entry for NCT01807689 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01807689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01807689 about?
NCT01807689 is a clinical study titled "Salivary Biomarkers for Sjögren's Syndrome Detection". This is a multi-center clinical study to compare the performance of a collective panel of salivary biomarkers to discriminate SS from non-SS in sicca cohorts recruited from three clinical sites with the diagnostic outcomes based on the new classification criteria for Sjögren's syndrome by the Americ...
What is the current status of trial NCT01807689?
This trial is currently completed. The enrollment target is 420 participants. The study started on 2013-04-01. Estimated completion is 2018-09-01.
Who is sponsoring clinical trial NCT01807689?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.